The PPARα/γ dual agonist chiglitazar improves insulin resistance and dyslipidemia in MSG obese rats

1. The aim of this study was to investigate the capacity of chiglitazar to improve insulin resistance and dyslipidemia in monosodium L-glutamate (MSG) obese rats and to determine whether its lipid-lowering effect is mediated through its activation of PPARα. 2. Chiglitazar is a PPARα/γ dual agonist....

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Li, Ping-Ping, Shan, Song, Chen, Yue-Teng, Ning, Zhi-Qiang, Sun, Su-Juan, Liu, Quan, Lu, Xian-Ping, Xie, Ming-Zhi, Shen, Zhu-Fang
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2006
Assuntos:
Papers
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC1751868/
https://ncbi.nlm.nih.gov/pubmed/16751799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjp.0706745
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados